Edesa Biotech, Inc.EDSANASDAQ
Loading
Operating Income Growth Under PressureDecelerating
Percentile Rank36
Studio
Year-over-Year Change

Year-over-year operating income growth rate

Percentile
P36
Within normal range
vs 3Y Ago
-0.6x
Contraction
Streak
2 yr
Consecutive declineDecelerating
PeriodValue
2025-12.78%
202423.94%
202349.80%
202222.43%
2021-269.97%
2020-126.01%
201944.23%
20182.80%
2017-6.44%
2016-13.13%